Native Renal Arteries Denervation as a Therapy of Refractory Hypertension in Patient after Heart and Kidney Transplantation-5 Years of Observation.
Justyna PilchJakub MizeraKrzysztof WiśnickiMarcin ProtasiewiczJacek KurczSławomir C ZmonarskiPatryk WawrzonkowskiKrzysztof LetachowiczDorota KamińskaTomasz GołębiowskiMichał ZakliczyńskiMagdalena KrajewskaMirosław BanasikPublished in: Journal of clinical medicine (2023)
This case report describes a 59-year-old male patient after heart and kidney transplantation, subsequently diagnosed with refractory hypertension since implemented antihypertensive pharmacotherapy consisting of six agents did not provide a substantial therapeutic response. Elevated blood pressure and its impact on a hypertrophied transplanted heart and impaired renal graft function have led to a significant deterioration in the patient's cardiovascular risk profile. To address this issue, a native renal arteries denervation was performed. It resulted in a noteworthy decrease in both systolic and diastolic pressure values, thus manifesting a positive hypotensive effect. Furthermore, a sustainable reduction of left ventricular mass and stabilization in kidney graft function were noticed. The presented case provides evidence that renal denervation can be an efficacious complementary treatment method in individuals who received kidney and heart grafts as it leads to a decrease in cardiovascular risk.
Keyphrases
- blood pressure
- kidney transplantation
- case report
- heart failure
- left ventricular
- hypertensive patients
- heart rate
- atrial fibrillation
- acute myocardial infarction
- type diabetes
- skeletal muscle
- stem cells
- cardiac resynchronization therapy
- insulin resistance
- aortic stenosis
- percutaneous coronary intervention
- mesenchymal stem cells
- mitral valve
- blood flow
- smoking cessation
- transcatheter aortic valve replacement
- replacement therapy